Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.
about
Advances in molecular imaging for breast cancer detection and characterizationRole of positron emission tomography for the monitoring of response to therapy in breast cancerPredicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopyMetabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.Imaging breast cancer chemotherapy response with light. Commentary on Soliman et al., p. 2605.Optically measured microvascular blood flow contrast of malignant breast tumors.Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinationsThe Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18F-FDG PET/CT Using PERCISTTumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancerOpportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigmDiffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient.Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic ImagingComparison of diffuse optical tomography of human breast with whole-body and breast-only positron emission tomography.Reproducibility of tumor blood flow quantification with 15O-water PET.Molecular imaging as a tool for translating breast cancer scienceTumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.Warburg revisited: imaging tumour blood flow and metabolism.Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.Blood flow and glucose metabolism in stage IV breast cancer: heterogeneity of response during chemotherapy.Methodology for quantitative rapid multi-tracer PET tumor characterizationsPET imaging for Treatment Response in Cancer¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis.Longitudinal optical monitoring of blood flow in breast tumors during neoadjuvant chemotherapy.Optical Mammography in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: Individual Clinical Response Index.Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy.Multiagent PET for risk characterization in sarcoma.Assessment of a statistical AIF extraction method for dynamic PET studies with 15O water and 18F fluorodeoxyglucose in locally advanced breast cancer patients.Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor.Tissue oxygen saturation predicts response to breast cancer neoadjuvant chemotherapy within 10 days of treatment
P2860
Q27000462-7922D3E5-5B16-4AC8-9064-E2CE57812A48Q28080621-65BCA78F-3066-43F0-BA0D-D8FCB47F1639Q33278673-5F3A1CD5-A4AC-4841-A89A-B81CFD0D9E01Q33369337-6EDBDB5C-79C2-4F1D-965C-B4E55E3FB47BQ33560611-95972D31-8FF6-41DE-890C-F5B75A1877C5Q33812407-BAA29299-7FBF-4309-87FD-2F13A78E4016Q33841446-F707E9BE-B3F7-4198-B455-9A512D0C61E7Q33860281-CFB28918-1F1F-42E4-A32E-8717A765D105Q33986198-936A5DC6-5D7C-415E-806F-5FAAD998C14EQ33994282-4E301793-E8A4-4732-83F0-5FCB69912AE3Q34050338-524E19B9-FF30-45E1-9FAE-7615EFCE152DQ34051790-1E5E8388-7927-491F-B8D7-423B5EDE7F11Q34074868-E74A20E6-B865-459E-97F4-C4358AE9DF63Q34257646-F83C5803-F2CF-4E34-9762-91F0C9661070Q34331734-0D5A7042-B541-4A8B-BB6E-0BDDFE115CC2Q34914187-A196E15E-8648-4265-B07D-1B4CA1C030DBQ35034709-CA6586C3-B40B-4282-B9A9-563D2B45B7EAQ36104503-D47C9CE7-8C02-48B0-B701-C3CEC16353BEQ36774229-2C24CA03-0F67-47F3-B21F-BE85828682FEQ36982972-5C293721-3754-4C12-B816-23CB123F4E0EQ37019264-2E7F24ED-AE4C-47B4-BC78-0755F3927ACFQ37121648-15D03EB8-FFA0-4469-B009-F1FB27BB8372Q37129062-61D07979-C452-4FDD-959C-C6DAD11B9378Q37217533-680FD09D-4042-41B8-BD0D-C9E4F7E6A298Q37228097-B18260CE-2DA5-4E60-83E0-53B03D7348FAQ37342653-361964AE-2C3F-44B1-9860-13354226B4A5Q37465205-C413891A-4234-49B9-829D-D83843FFAA53Q37582345-953BB484-1BFE-4791-9B9E-51A98805D87BQ38641832-5BE9BC1C-529A-4E0C-A475-B29B38D9E3B2Q38731390-F97D8764-5E2C-44D5-A3B2-8B67E2B906E0Q38770341-6B5F1A23-FFC6-41C9-A226-CA938B3A334EQ41631094-8886A1FF-4D45-4EFA-B9E7-2E64C81665D5Q42283582-F50E489D-C56F-4FE3-9A06-ADBA59FAD624Q47588877-4278FF13-EB67-4364-B1A9-DC608AAD6F67Q54118788-8365B3F5-1B23-461D-8F01-22965E2CDBA5Q58594837-8786B395-19A6-4DA4-B78E-CB52392D7731
P2860
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Changes in blood flow and meta ...... with neoadjuvant chemotherapy.
@en
Changes in blood flow and meta ...... with neoadjuvant chemotherapy.
@nl
type
label
Changes in blood flow and meta ...... with neoadjuvant chemotherapy.
@en
Changes in blood flow and meta ...... with neoadjuvant chemotherapy.
@nl
prefLabel
Changes in blood flow and meta ...... with neoadjuvant chemotherapy.
@en
Changes in blood flow and meta ...... with neoadjuvant chemotherapy.
@nl
P2093
P1476
Changes in blood flow and meta ...... with neoadjuvant chemotherapy
@en
P2093
David A Mankoff
Erin K Schubert
Georgiana K Ellis
Hannah M Linden
Jeffrey Tseng
Julie R Gralow
Lisa K Dunnwald
Robert B Livingston
Thomas J Lawton
P304
P407
P577
2003-11-01T00:00:00Z